Compare · CERS vs TWTR
CERS vs TWTR
Side-by-side comparison of Cerus Corporation (CERS) and Twitter Inc. (TWTR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CERS and TWTR operate in EDP Services (Technology), so they compete in similar markets.
- TWTR is the larger of the two at $28.20B, about 48.0x CERS ($587.1M).
- CERS has hit the wire 3 times in the past 4 weeks while TWTR has been quiet.
- TWTR has more recent analyst coverage (25 ratings vs 4 for CERS).
- Company
- Cerus Corporation
- Twitter Inc.
- Price
- $2.94+2.08%
- $53.83+0.77%
- Market cap
- $587.1M
- $28.20B
- 1M return
- +11.57%
- -
- 1Y return
- +116.18%
- -
- Industry
- EDP Services
- EDP Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 1997
- 2013
- News (4w)
- 3
- 0
- Recent ratings
- 4
- 25
Cerus Corporation
Cerus Corporation, a biomedical products company, focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation has collaboration with LifeSouth Community Blood Centers to manufacture INTERCEPT Fibrinogen Complex. The company was incorporated in 1991 and is headquartered in Concord, California.
Twitter Inc.
Twitter, Inc. operates as a platform for public self-expression and conversation in real time United States, Japan, and internationally. The company offers Twitter, a platform that allows users to consume, create, distribute, and discover content. It also provides promoted products and services, such as promoted tweets, promoted accounts, and promoted trends, which enable its advertisers to promote their brands, products, and services. In addition, the company offers MoPub, a mobile-focused advertising exchange that combines ad serving, ad network mediation, and a real-time bidding exchange into one monetization platform; Twitter Audience platform, an advertising offering that enables advertisers to extend advertising campaigns; Developer and Enterprise solutions, a software-as-a-service platform that enables developers to build products on Twitter; and paid enterprise access for its public data streams. Twitter, Inc. was founded in 2006 and is headquartered in San Francisco, California.
Latest CERS
- Chief Executive Officer Jayaraman Vivek K sold $52,665 worth of shares (16,666 units at $3.16) as part of a pre-agreed trading plan, decreasing direct ownership by 0.74% to 2,232,211 units (SEC Form 4)
- Cerus Corporation to Release Second Quarter 2026 Financial Results on July 30, 2026
- Cerus Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Chief Financial Officer Green Kevin Dennis sold $99,105 worth of shares (33,676 units at $2.94) as part of a pre-agreed trading plan and gave a grant of 63,600 shares, decreasing direct ownership by 8% to 1,062,188 units (SEC Form 4) to cover withholding tax
- Chief Operating Officer Jayaraman Vivek K was granted 554,529 shares, gave a grant of 80,000 shares and sold $124,658 worth of shares (42,359 units at $2.94) as part of a pre-agreed trading plan, increasing direct ownership by 24% to 2,248,877 units (SEC Form 4) to satisfy withholding obligation
- Chief Legal Officer Jensen Chrystal gave a grant of 55,000 shares and sold $71,598 worth of shares (24,329 units at $2.94) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 966,657 units (SEC Form 4) (for withholding tax)
- President and CEO Greenman William Mariner gave a grant of 192,500 shares and sold $299,937 worth of shares (101,919 units at $2.94) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 5,053,036 units (SEC Form 4) to cover taxes
- Cerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT Congress
- Director Bjerkholt Eric sold $53,180 worth of shares (20,454 units at $2.60), decreasing direct ownership by 7% to 261,679 units (SEC Form 4)
- Cerus Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation
Latest TWTR
- NY Gov Hochul's Latest Crackdown On Illicit Cannabis Operations Has The Big Apple In Its Crosshairs
- Biden's Health Secretary Stalls On Completing Marijuana Review By 4/20
- As Twitter Moves Forward With Cannabis Advertising, Meta Really Should Get With The Program
- Elon Musk's Decision To Allow Cannabis Ads On Twitter: It's A New Frontier And Benzinga Is Part Of It
- Elon Musk Tweets A Simple Yet Powerful Pro-Marijuana Message, Reaches Millions Around The World
- Google Ads For Cannabis: New Policy Change To Allow Advertising In These States
- Boobs And Bud: Is It Time To Go Back To Tumblr? Weed Friendly Social Network Allows Nudity Again
- SEC Form 4: Agrawal Parag returned 927,806 shares to the company, closing all direct ownership in the company
- SEC Form 4: Gadde Vijaya returned 1,097,589 shares to the company, closing all direct ownership in the company
- SEC Form 4: Segal Ned D. returned 945,546 shares to the company, closing all direct ownership in the company